These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20688140)

  • 1. Evaluation of ISCOM matrices clearance from rabbit nasal cavity by γ scintigraphy.
    Pandey RS; Babbar AK; Kaul A; Mishra AK; Dixit VK
    Int J Pharm; 2010 Oct; 398(1-2):231-6. PubMed ID: 20688140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy.
    Tafaghodi M; Abolghasem Sajadi Tabassi S; Jaafari MR; Zakavi SR; Momen-Nejad M
    Int J Pharm; 2004 Aug; 280(1-2):125-35. PubMed ID: 15265553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
    Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
    Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status and potential application of ISCOMs in veterinary medicine.
    Morein B; Hu KF; Abusugra I
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma scintigraphy for testing bioequivalence: a case study on two cromolyn sodium nasal spray preparations.
    Al-Ghananeem AM; Sandefer EP; Doll WJ; Page RC; Chang Y; Digenis GA
    Int J Pharm; 2008 Jun; 357(1-2):70-6. PubMed ID: 18329197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of alginate microspheres of carvedilol for nasal delivery.
    Patil SB; Kaul A; Babbar A; Mathur R; Mishra A; Sawant KK
    J Biomed Mater Res B Appl Biomater; 2012 Jan; 100(1):249-55. PubMed ID: 22113887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix.
    Rönnberg B; Fekadu M; Morein B
    Vaccine; 1995 Oct; 13(14):1375-82. PubMed ID: 8585296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of IMXQB: Nanoparticles Based on Quillaja brasiliensis Saponins to be Used as Vaccine Adjuvants.
    Rivera-Patron M; Cibulski SP; Miraballes I; Silveira F
    Methods Mol Biol; 2022; 2469():183-191. PubMed ID: 35508839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance characteristics of chitosan based formulations in the sheep nasal cavity.
    Soane RJ; Hinchcliffe M; Davis SS; Illum L
    Int J Pharm; 2001 Apr; 217(1-2):183-91. PubMed ID: 11292554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal residence of insulin containing lyophilised nasal insert formulations, using gamma scintigraphy.
    McInnes FJ; O'Mahony B; Lindsay B; Band J; Wilson CG; Hodges LA; Stevens HN
    Eur J Pharm Sci; 2007 May; 31(1):25-31. PubMed ID: 17368006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISCOM-Matrices Nanoformulation Using the Raw Aqueous Extract of
    Cibulski S; de Souza TA; Raimundo JP; Nascimento YM; Abreu LS; Suarez N; Miraballes I; Roehe PM; de Araújo DAM; Tavares JF; da Silva MS; Silveira F
    Bionanoscience; 2022; 12(4):1166-1171. PubMed ID: 35967762
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen: involvement of marginal metallophilic macrophages in the uptake of immune-stimulating complexes.
    Claassen IJ; Osterhaus AD; Claassen E
    Eur J Immunol; 1995 May; 25(5):1446-52. PubMed ID: 7774649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydration of lipid films with an aqueous solution of Quil A: a simple method for the preparation of immune-stimulating complexes.
    Copland MJ; Rades T; Davies NM
    Int J Pharm; 2000 Mar; 196(2):135-9. PubMed ID: 10699704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal distribution of radioactive drug administered using two dosage forms.
    Vidgren P; Vidgren M; Paronen P; Vainio P; Nuutinen J
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():426-32. PubMed ID: 1820917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nose-to-brain delivery of tacrine.
    Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
    J Pharm Pharmacol; 2007 Sep; 59(9):1199-205. PubMed ID: 17883890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudo-ternary phase diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by the lipid-film hydration method.
    Demana PH; Davies NM; Vosgerau U; Rades T
    Int J Pharm; 2004 Feb; 270(1-2):229-39. PubMed ID: 14726138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms.
    Behboudi S; Morein B; Rönnberg B
    Vaccine; 1995 Dec; 13(17):1690-6. PubMed ID: 8719521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iscom, a delivery system for parenteral and mucosal vaccination.
    Morein B; Villacrés-Eriksson M; Lövgren-Bengtsson K
    Dev Biol Stand; 1998; 92():33-9. PubMed ID: 9554257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B.
    Pandey RS; Dixit VK
    J Drug Target; 2010 May; 18(4):282-91. PubMed ID: 19958131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity.
    Rönnberg B; Fekadu M; Behboudi S; Kenne L; Morein B
    Vaccine; 1997 Dec; 15(17-18):1820-6. PubMed ID: 9413088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.